Ke Hui

629 total citations
21 papers, 451 citations indexed

About

Ke Hui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ke Hui has authored 21 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Ke Hui's work include Prostate Cancer Treatment and Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Ke Hui is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Ke Hui collaborates with scholars based in China, United States and Australia. Ke Hui's co-authors include Kaijie Wu, Dalin He, Xinyang Wang, Jer‐Tsong Hsieh, Jinhai Fan, Bin Wang, Shiqi Wu, Jun Huang, Shan Xu and Yanan Gu and has published in prestigious journals such as The Journal of Urology, Cell Death and Disease and Oncotarget.

In The Last Decade

Ke Hui

21 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Hui China 12 315 160 77 62 50 21 451
Ralitsa R. Madsen United Kingdom 11 280 0.9× 104 0.7× 103 1.3× 55 0.9× 46 0.9× 18 499
Agnese Di Rocco United States 12 282 0.9× 105 0.7× 115 1.5× 84 1.4× 39 0.8× 13 447
Jingping Ge China 10 368 1.2× 193 1.2× 67 0.9× 102 1.6× 33 0.7× 38 588
Alessia Brossa Italy 14 402 1.3× 165 1.0× 87 1.1× 68 1.1× 27 0.5× 22 598
Huinan Qu China 10 228 0.7× 124 0.8× 74 1.0× 75 1.2× 31 0.6× 17 402
Laura Pietrovito Italy 9 206 0.7× 172 1.1× 94 1.2× 65 1.0× 30 0.6× 13 361
Rui Liang China 12 353 1.1× 151 0.9× 86 1.1× 46 0.7× 42 0.8× 32 490
Cécile Pierre‐Eugène France 11 267 0.8× 99 0.6× 82 1.1× 37 0.6× 31 0.6× 17 427
Tianshi Que China 8 351 1.1× 248 1.6× 64 0.8× 60 1.0× 28 0.6× 15 480
Federica Parodi Italy 12 330 1.0× 164 1.0× 120 1.6× 71 1.1× 32 0.6× 21 566

Countries citing papers authored by Ke Hui

Since Specialization
Citations

This map shows the geographic impact of Ke Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Hui more than expected).

Fields of papers citing papers by Ke Hui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Hui. The network helps show where Ke Hui may publish in the future.

Co-authorship network of co-authors of Ke Hui

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Hui. A scholar is included among the top collaborators of Ke Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Hui. Ke Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Huaijun, et al.. (2024). Action recognition method based on multi-stream attention-enhanced recursive graph convolution. Applied Intelligence. 54(20). 10133–10147. 2 indexed citations
3.
Wang, Huaijun, et al.. (2024). 3D human pose estimation method based on multi-constrained dilated convolutions. Multimedia Systems. 30(5). 2 indexed citations
4.
Hui, Ke, et al.. (2024). Relationship between physical exercise and mental health of college students: Chain mediating role of fulfillment of basic psychological needs and peer relationships. Social Behavior and Personality An International Journal. 52(10). 1–9. 5 indexed citations
5.
Yang, Wenjie, Ke Wang, Jianbin Ma, et al.. (2020). Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression. Archives of Medical Research. 52(2). 174–181. 8 indexed citations
6.
Yue, Yangyang, Ke Hui, Shiqi Wu, et al.. (2020). MUC15 inhibits cancer metastasis via PI3K/AKT signaling in renal cell carcinoma. Cell Death and Disease. 11(5). 336–336. 22 indexed citations
7.
Hui, Ke, et al.. (2020). PD59-04 PROX1 AS A NEW DRIVER IN THE REGULATION OF NEUROENDOCRINE DIFFERENTIATION AND CELLULAR PLASTICITY IN PROSTATE CANCER. The Journal of Urology. 203(Supplement 4). 1 indexed citations
8.
Yu, Min, Li Sun, Linghua Liu, et al.. (2019). Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma. Journal of Computational Biology. 27(7). 1067–1078. 15 indexed citations
9.
Hui, Ke, Shiqi Wu, Yangyang Yue, et al.. (2018). RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer. Cellular Signalling. 48. 38–44. 20 indexed citations
10.
Wang, Bin, Yanan Gu, Ke Hui, et al.. (2018). AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling. Urologic Oncology Seminars and Original Investigations. 36(10). 472.e11–472.e20. 41 indexed citations
11.
Hui, Ke, Yangyang Yue, Shiqi Wu, et al.. (2018). The expression and function of RASAL2 in renal cell carcinoma angiogenesis. Cell Death and Disease. 9(9). 881–881. 19 indexed citations
13.
Wang, Hao, et al.. (2017). [Expressions of survivin, PI3K and AKT in keratinocytes in skin lesions and their pathogenic role in psoriasis vulgaris].. Europe PMC (PubMed Central). 37(11). 1512–1516. 10 indexed citations
14.
Hui, Ke, Yang Gao, Jun Huang, et al.. (2017). RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer. Cell Death and Disease. 8(2). e2600–e2600. 39 indexed citations
15.
Shi, Qi, Jing Jia, Ke Hui, et al.. (2017). KLF5 promotes apoptosis induced by phorbol ester as an effector of the autocrine factor TNFα in LNCaP prostate cancer cells. Oncology Letters. 14(2). 1847–1854. 5 indexed citations
16.
Wang, Bin, Jun Huang, Jiancheng Zhou, et al.. (2016). DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1α protein. Cellular Signalling. 28(11). 1623–1630. 19 indexed citations
17.
Huang, Jun, Bin Wang, Ke Hui, et al.. (2016). miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion. Oncology Reports. 36(3). 1693–1701. 35 indexed citations
18.
Hui, Ke, Kaijie Wu, Jinhai Fan, & Dalin He. (2016). MP45-20 RASAL2, A NOVEL RAS GTPASE ACTIVATING PROTEIN, INHIBITS STEMNESS AND EPITHELIAL-MESENCHYMAL TRANSITION VIA MAPK/SOX2 PATHWAY IN BLADDER CANCER. The Journal of Urology. 195(4S). 1 indexed citations
19.
Wu, Kaijie, Bin Wang, Yule Chen, et al.. (2015). DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling. Cellular Signalling. 27(12). 2515–2523. 29 indexed citations
20.
Yu, Weihua, Zhenguang Chen, Jinli Zhang, et al.. (2007). Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells. Molecular and Cellular Biochemistry. 310(1-2). 11–18. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026